aTyr Pharma Inc. to Present Data for Inflammatory Myopathy and Interstitial Lung Disease at the 2012 American College of Rheumatology Annual Meeting
11/8/2012 10:54:32 AM
More...
|
aTyr Pharma Inc. Receives Industry Innovation Awards from TiE and San Diego Venture Group
6/18/2012 11:56:41 AM
More...
|
aTyr Pharma Inc. Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology
8/30/2011 10:14:46 AM
More...
|
aTyr Pharma Inc. Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology
6/17/2011 7:04:20 AM
More...
|
Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma Inc. to Advance Physiocrine-based Therapeutics
5/18/2011 9:16:04 AM
More...
|
aTyr Pharma Inc. Announces Formation of Therapeutic Advisory Board
3/1/2011 10:18:29 AM
More...
|
aTyr Pharma Inc. Appoints Catharine E. Johnson As Senior Vice President of Business Development
6/14/2010 10:29:42 AM
More...
|
Dr. John Mendlein Joins aTyr Pharma Inc. as Executive Chairman
5/25/2010 9:17:57 AM
More...
|
aTyr Pharma Inc. Publishes Groundbreaking Research
12/14/2009 1:21:08 PM
More...
|
Dr. Floyd Bloom Joins aTyr Pharma Inc.'s Scientific Advisory Board
10/14/2009 10:48:10 AM
More...
|
|